About Karen LeVert
Form D filings for Lindy Biosciences from 2018 to 2024 list Karen LeVert as director.
Karen LeVert first appears on SEC filings in 2018.
Experience
This experience comes from SEC filings. The years are when the filings name Karen LeVert in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Karen LeVert works with at each company, as listed on that company's latest Form D.
Lindy Biosciences, Inc. · Form D, Mar 19, 2024
OF
Omar Flores
Executive officer and director
DB
Deborah Bitterfield
CEO and director
JW
Joel Whitley
Director